@realDonaldTrump
President Trump,
As you work to drain the swamp and restore integrity to Washington, I urge you to investigate potential conflicts of interest among several Democratic members of Congress who actively traded stocks in major health insurance companies—such as UnitedHealth Group (UNH), Elevance Health (ELV), Cigna (CI), Humana (HUM), CVS Health (CVS), and Centene (CNC)—while voting against the recent Continuing Resolution (H.R. 5371, the Continuing Appropriations and Extensions Act, 2026). These companies have profited immensely from ACA subsidies, and the CR's funding implications could directly impact their revenues.
Key individuals include:
- Rep. Valerie Hoyle (D-OR): Sold shares in UNH, CI, and CVS in September 2025, shortly before voting no on the House passage.
- Rep. Ro Khanna (D-CA): Multiple trades across all six stocks in July-September 2025, then voted no.
- Rep. Gil Cisneros (D-CA): Trades in UNH, HUM, CI, ELV, and CNC in April-September 2025, followed by a no vote.
- Rep. Julie Johnson (D-TX): Sold shares in UNH, CI, and CVS in April-September 2025, then voted no.
- Rep. Jared Moskowitz (D-FL): Purchased CI shares in May 2025, then voted no.
- Sen. Sheldon Whitehouse (D-RI): Sold UNH shares in September 2025, then voted no on the Senate cloture.
These actions raise serious questions about whether personal financial interests influenced their opposition to the bill, potentially violating ethics rules under the STOCK Act. A thorough investigation by the DOJ or congressional ethics committees is essential to ensure transparency and accountability.
America deserves leaders who put the people first—not their portfolios. Let's make government work for us again. CC
@AGPamBondi @SenateGOP @HouseGOP